Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Total 13F shares
-
240,511,936
-
Share change
-
+867,176
-
Total reported value
-
$39,191,663,333
-
Put/Call ratio
-
95%
-
Price per share
-
$162.98
-
Number of holders
-
674
-
Value change
-
+$165,476,417
-
Number of buys
-
331
-
Number of sells
-
291
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q1 2018
As of 31 Mar 2018,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
674 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
240,511,936 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Capital World Investors, JPMORGAN CHASE & CO, JENNISON ASSOCIATES LLC, and Clearbridge Investments, LLC.
This page lists
675
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.